Tag: CX 2022
“Interesting developments” in aortic therapy trends, new complex devices and future...
Tilo Kölbel (Hamburg, Germany) speaks to CX Live about new, innovative developments within devices and recent results of large studies producing data that poses...
First vascular surgery training requirements looks to harmonise European curriculum
Armando Mansilha (Porto, Portugal) tells CX Live about the recent publication of the first European training requirements in vascular surgery. Published in International Angiology,...
Intravascular ultrasound given “unanimous approval” in consensus document for peripheral procedural...
Speaking to CX Live, Eric Secemsky (Boston, USA) delves into the emerging use of intravascular ultrasound (IVUS) in the peripheral procedural phases—outlining contemporary studies...
Experts react to “compelling” 36-month IN.PACT AV Access trial data
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris,...
Roundtable: Will latest IN.PACT AV Access data impact practice and can...
NOTE: This video is ONLY available to watch in selected countries and geographies
In this Vascular News roundtable, Andrew Holden (moderator; Auckland, New Zealand) is joined...
Disruptive technology and high-quality clinical evidence: An Endologix transformation
NOTE: This video is ONLY available to watch in selected countries and geographies
Endologix president and CEO, Matt Thompson (Irvine, USA), discusses how the...
Shockwave IVL: Seeing is believing
Raphaël Coscas (Paris, France) talks to Vascular News about his introduction to Intravascular Lithotripsy (IVL; Shockwave Medical) and his initial experiences with the technology in...
Vascular News’ top 10 most popular stories of May 2022
Two-year data on the use of intravascular lithotripsy (IVL) in calcified peripheral disease treatment, an advertorial sponsored by Bentley exploring the role of bridging...
Vascular News 94 – June 2022 US Edition
In this issue:
Community-focused approach required to tackle global issue of unnecessary amputations
Perioperative outcomes of carotid endarterectomy not improved on dual versus single...
Vascular News 94 – June 2022 OUS Edition
In this issue:
Community-focused approach required to tackle global issue of unnecessary amputations
Perioperative outcomes of carotid endarterectomy not improved on dual versus single...
First time data release: View the full IN.PACT AV Access trial...
NOTE: This video is ONLY available to watch in selected countries and geographies
In a late-breaking Podium 1st presentation at the 2022 Charing Cross...
Artificial intelligence could make endovascular aortic repair outcomes more predictable
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London, UK), Tom Carrell (Cydar Medical, Barrington, UK) delivered a Podium 1st presentation titled...
IN.PACT AV Access: Three-year data support use of paclitaxel-coated balloon as...
The 36-month results from the IN.PACT AV Access study (Medtronic)—which were presented for the first time during at the 2022 Charing Cross (CX) International...
Five-year patient-level data confirm safety of Passeo-18 Lux paclitaxel DCB
New long-term data presented at the 2022 Charing Cross (CX) Symposium (26–28 April, London, UK) demonstrate the safety of Biotronik’s Passeo-18 Lux paclitaxel drug-coated...
Restorative Axess graft demonstrates promising patency and safety in first-in-human study
The preliminary results from a clinical trial assessing a restorative haemodialysis access graft have shown promising early puncturing, patency and safety data. These findings...
Vascular News – CX Special Edition 2022 US
In this issue:
What to expect from CX 2022
A year in profiles: Ali AbuRahma, Michael Jenkins, Joseph Bavaria, and Palma Shaw
Vascular News debuts a...
Vascular News – CX Special Edition 2022 OUS
In this issue:
What to expect from CX 2022
A year in profiles: Ali AbuRahma, Michael Jenkins, Joseph Bavaria, and Palma Shaw
Vascular News...
CX 2022: A conversation with Robert Hinchliffe
Robert Hinchliffe (University of Bristol, Bristol, UK) shares his excitement to attend the upcoming CX Symposium in April. “CX has always represented an unprecedented...
Vascular News 93 – March 2022 US Edition
In this issue:
Population-based data project unmasks “frightening” trends in worldwide vascular disease burden
CX 2022 returns to in-person format, faces challenges and opportunities...
Vascular News 93 – March 2022 OUS Edition
In this issue:
Population-based data project unmasks "frightening" trends in worldwide vascular disease burden
CX 2022 returns to in-person format, faces challenges and opportunities...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
